Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure

Acta Histochemica

Volumn 116, Issue 8, 2014, Pages 1342-1349

  Cohen Segev, Ravit ^a   Francis, Bahaa ^a   Abu Saleh, Niroz ^a   Awad, Hoda ^a   Lazarovich, Aviva ^a   Kabala, Aviva ^a   Aronson, Doron ^b   Abassi, Zaid ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Angiotensin 1 7; Angiotensin converting enzyme; Angiotensin converting enzyme 2; Angiotensin II; Heart failure; Kidney; Rat

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALIA; RATTUS;

EID: 84919386958     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.08.006     Document Type: Article

References (47)

1. Abassi Z., Goltsman I., Karram T., Winaver J., Hoffman A. Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol 2011, 729497. 10.1155/2011/729497.
2. Abassi Z., Bishara B., Karram T., Khatib S., Winaver J., Hoffman A. Adverse effects of pneumoperitoneum on renal function: involvement of the endothelin and nitric oxide systems. Am J Physiol Regul Integr Comp Physiol 2008, 294:R842-R850.
3. Abassi Z., Francis B., Wessale J., Ovcharenko E., Winaver J., Hoffman A. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure. Clin Sci (Lond) 2002, 103(Suppl 48):245S-248S.
4. Abassi Z., Gurbanov K., Rubinstein I., Better O.S., Hoffman A., Winaver J. Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. Am J Physiol 1998, 274:F766-F774.
5. Batlle D., Wysocki J., Soler M.J., Ranganath K. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int 2012, 81:520-528.
6. Bernardi S. High-salt diet increases glomerular ACE/ACE-2 ratio leading to oxidative stress and kidney damage. Nephrol Dial Transplant 2012, 27:1793-1800.
7. Bishara B., Karram T., Khatib S., Ramadan R., Schwartz H., Hoffman A., et al. Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine. Surg Endosc 2009, 23:568-576.
8. Braunwald E., Bristow M.R. Congestive heart failure: fifty years of rogress. Circulation 2000, 102(20 Suppl 4):IV14-IV23.
9. Burrell L.M., Burchill L., Dean R.G., Griggs K., Patel S.K., Velkoska E. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Exp Physiol 2012, 97:477-485.
10. Burrell L.M., Risvanis J., Kubota E., Dean R.G., MacDonald P.S., Lu S., et al. Myocardial infarction increases ACE-2 expression in rat and humans. Eur Heart J 2005, 26:369-375.
11. Clarke N.E., Fisher M.J., Porter K.E., Lambert D.W., Turner A.J. Angiotensin converting enzyme (ACE) and ACE-2 bind integrins and ACE-2 regulates integrin signalling. PLoS One 2012, 7:e34747.
12. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., et al. Angiotensin-converting-enzyme-2 is an essential regulator of heart function. Nature 2002, 417:822-828.
13. Cruz D.N. Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes. Adv Chronic Kidney Dis 2013, 20:56-66.
14. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., et al. A novel angiotensin-converting enzyme-related carboxypeptidase converts angiotensin I to angiotensin 1-9. Circ Res 2000, 87:E1-E9.
15. Dzau V.J. Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987, 31:1402-1415.
16. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990, 82:1724-1729.
17. Grobe J.L., Mecca A.P., Lingis M., Shenoy V., Bolton T.A., Machado J.M., et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 2007, 292:H736-H742.
18. Goulter A.B., Goddard M.J., Allen J.C., Clark K.L. ACE-2 gene expression is up-regulated in the human failing heart. BMC Med 2004, 2:19. 10.1186/1741-7015-2-19.
19. Igase M., Yokoyama H., Ferrario C.M. Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7). Ther Adv Cardiovasc Dis 2011, 5:297-304.
20. Iwai M., Nakaoka H., Senba I., Kanno H., Moritani T., Horiuchi M. Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling. Hypertension 2012, 60:137-144.
21. Jessup M., Brozena S. Heart failure. N Engl J Med 2003, 348:2007-2018.
22. Johnson J.A., West J., Maynard K.B., Hemnes A.R. ACE-2 improves right ventricular function in a pressure overload model. PLoS One 2011, 6(6):pe20828.
23. Katz A.M. Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses. J Cell Mol Med 2003, 7:1-10.
24. Keidar S., Kaplan M., Gamliel-Lazarovich A. ACE-2 of the heart: From angiotensin I to angiotensin (1-7). Cardiovasc Res 2007, 73:463-469.
25. Kobori H., Nangaku M., Navar L.G., Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007, 59:251-287.
26. Kurdi M., Booz G.W. New take on the role of angiotensin II in cardiac hypertrophy and fibrosis. Hypertension 2011, 57:1034-1038.
27. Metra M., Cotter G., Gheorghiade M., Dei Cas L., Voors A.A. The role of the kidney in heart failure. Eur Heart J 2012, 33:2135-2142.
28. Mizuiri S., Hemmi H., Arita M., Ohashi Y., Tanaka Y., Miyagi M., et al. Expression of ACE and ACE-2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 2008, 51:613-623.
29. Napoli C., Casamassimi A., Crudele V., Infante T., Abbondanza C. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework. Future Cardiol 2011, 7:485-497.
30. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992, 20:248-254.
31. Patel K.P., Schultz H.D. Angiotensin peptides and nitric oxide in cardiovascular disease. Antioxid Redox Signaling 2013, 19:1121-1132.
32. Patel V.B., Bodiga S., Fan D., Das S.K., Wang Z., Wang W., et al. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Hypertension 2012, 59:1195-1203.
33. Prieto M.C., González-Villalobos R.A., Botros F.T., Martin V.L., Pagán J., Satou R., et al. Reciprocal changes in renal ACE/ANG II and ACE-2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 2011, 300:F749-F755.
34. Ronco C., Chionh C.Y., Haapio M., Anavekar N.S., House A., Bellomo R. The cardiorenal syndrome. Blood Purif 2009, 27:114-126.
35. Ross E.A. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail 2012, 18:930-938.
36. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 1999, 341:577-585.
37. Schroten N.F., Gaillard C.A., van Veldhuisen D.J., Szymanski M.K., Hillege H.L., de Boer R.A. New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev 2012, 17:191-201.
38. Soler M.J., Wysocki J., Ye M., Lloveras J., Kanwar Y., Batlle D. ACE-2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 2007, 72:614-623.
39. Szatalowicz V.L., Arnold P.E., Chaimovitz C., Bichet D., Berl T., Schrier R.W. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 1981, 305:263-266.
40. Tikellis C., Pickering R., Tsorotes D., Du X.J., Kiriazis H., Nguyen-Huu T.P., et al. Interaction of diabetes and ACE-2 in the pathogenesis of cardiovascular disease in experimental diabetes. Clin Sci (Lond) 2012, 123:519-529.
41. Tikellis C., Bialkowski K., Pete J., Sheehy K., Su Q., Johnston C., et al. ACE-2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008, 57:1018-1025.
42. Tsuruda T., Boerrigter G., Huntley B.K., Noser J.A., Cataliotti A., Costello-Boerrigter L.C., et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 2002, 91:1127-1134.
43. Verano-Braga T1, Schwämmle V., Sylvester M., Passos-Silva D.G., Peluso A.A., Etelvino G.M., et al. Time-resolved quantitative phosphoproteomics: new insights into angiotensin-(1-7) signaling networks in human endothelial cells. J Proteome Res 2012, 11:3370-3381.
44. Woodard G.E., Rosado J.A. Recent advances in natriuretic peptide research. J Cell Mol Med 2007, 11:1263-1271.
45. Ye M., Wysocki J., William J., Soler M.J., Cokic I., Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006, 17:3067-3075.
46. Zhu Q., Wang Z., Xia M., Li P.L., Van Tassell B.W., Abbate A., et al. Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 2011, 58:657-664.
47. Zisman L.S., Keller R.S., Weaver B., Lin Q., Speth R., Bristow M.R., et al. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE-2. Circulation 2003, 108:1707-1712.